Skip to content

Brachial Plexus Birth Palsy: Reinforcement Paradigm to Augment Recovery

A Home-Based Biofeedback Program to Augment Recovery After Perinatal Brachial Plexus Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03886792
Enrollment
24
Registered
2019-03-22
Start date
2019-02-25
Completion date
2021-12-31
Last updated
2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachial Plexus Palsy

Brief summary

Infants who sustain an injury to the brachial plexus in the perinatal period are at high-risk for long-term neuromuscular deficits and prehensile dysfunction. If recovery is delayed because of slow axonal regrowth, disuse atrophy and secondary musculoskeletal deficits may develop. The investigators' hypothesis is that early, intensive intervention designed to foster muscle activation is essential to optimize outcomes after brachial plexus injury and may supplement rehabilitation and microsurgery. This proposal targets infants who are non-surgical candidates. Yet, future studies will examine whether the investigators' experimental intervention can hasten recovery from microsurgery and will examine which post-operative time-point is best to employ it. The investigators' intervention shows promise to increase muscle activation and improve arm function in infants with brachial plexus birth palsy (BPBP) through contingent reinforcement based on a pilot study.

Detailed description

The investigator's study objectives are to (1) test the feasibility of a parent-lead in-home 2-week intervention for infants with BPBP; and (2) determine the effect size for the primary outcome measure(s) in preparation for a future definitive randomized controlled trial (RCT). In this feasibility RCT, the investigators will compare two in-home interventions in 3 to 12-month-old infants with upper trunk BPBP; n=12 per group: (1) experimental; and (2) dose-equivalent active control. For the experimental intervention, infants will trigger a musical toy to move and play via biceps contraction above a preset individual threshold. For the control intervention, toys will be available to play with, yet, there will be no reinforcement for biceps activation.

Interventions

BEHAVIORALTriggered reinforcement

This group will participate in a home-based experimental intervention for 10 minutes, twice/day for 10 days within 2 weeks. The infants will be supported in sitting with a tray secured anterior to the trunk. This intervention will involve reinforcement of biceps muscle activation in the affected arm if the infant generates a muscle contraction above a pre-set threshold (V). The threshold needed to trigger a toy to move and make sounds (reinforcement) will be set at baseline as determined by surface electromyography (SEMG). During the training time-points, the parent or care-giver will be allowed to sing or talk to the infant but are not to shake the toys or place dowel-based rattles or toys in either palm of the infant.

BEHAVIORALSocial interaction

This group will participate in a home-based dose-equivalent control intervention for 10 minutes, twice/day for 10 days within 2 weeks. The infants will be supported in sitting with a tray. This control program will combine social interaction between infant/parent with the opportunity for self-initiated play with toys repeatedly placed on the tray. A toy will be placed in front of the infant seat and tray but it will not be connected to the SEMG unit nor will the infant have an SEMG electrode attached over the biceps. During the intervention, the parent or care-giver will be allowed to sing or talk to the infant but are not to shake the toys or place dowel-based rattles or toys in either palm of the infant.

Sponsors

American Society for Surgery of the Hand
CollaboratorOTHER
Chapman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blind to treatment group

Intervention model description

Feasibility Randomized Controlled Trial with one experimental and one control group

Eligibility

Sex/Gender
ALL
Age
3 Months to 12 Months
Healthy volunteers
No

Inclusion criteria

1. Age of 3 to 12 months with upper trunk brachial plexus birth palsy confirmed by an attending Hand and Upper Extremity Surgeon; 2. Full-term at birth; 3. A minimum score of '1' (0-7 scale) in elbow flexion of affected arm (isometric contraction) based on the Active Movement Scale (AMS); 4. Score ≥ 25th percentile on the motor subtest of the Bayley Scales of Infant and Toddler Development, 3rd Edition (BSITD-III®); 5. Ability to sustain attention/arousal for a 10 minute training period based on criteria from the Neonatal Behavioral Assessment for an awake-alert state.

Exclusion criteria

1. Visual/auditory deficits; 2. Nerve repair/shoulder surgery; 3. Excessive crying during session(s); 4. Shoulder, elbow, or wrist joint contractures \> 20° in the affected arm; 5. An inability to trigger the musical-toy to play at baseline.

Design outcomes

Primary

MeasureTime frameDescription
Change in the integral of biceps brachii muscle activation post-interventionBaseline, Immediately post-intervention, 1-month post-intervention, 3-months post-interventionChange in the magnitude of biceps muscle activation (Volts x time) post-intervention

Secondary

MeasureTime frameDescription
Change in day-long arm activity based on the resultant acceleration (ms*m/s2)Baseline, Immediately post-intervention, 1-month post-intervention, 3-months post-interventionResultant acceleration of arm activity (ms\*m/s2) over one daytime period
Parent Perception Questionnaire to examine feasibility of parent-run intervention - self designedImmediately post-interventionParent Perception Questionnaire with responses based on short-answer and a 5-point Likert scale. The Likert scale will measure responses on a 1-5 range with lower scores indicating a better outcome. A frequency distribution will be used to represent the responses on each Likert subscale.

Countries

United States

Contacts

Primary ContactSusan V Duff, EdD, PT, OT
duff@chapman.edu(714) 977-6704
Backup ContactJamie Berggren, OTR/L
jberggren@chla.usc.edu(323) 361-4165

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026